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Faster elimination of drug tolerant ‘persister’ bacteria may shorten treatment of tuberculosis (TB) but no
method exists to quantify persisters in clinical samples. We used automated image analysis to assess
whether studying growth characteristics of individual Mycobacterium tuberculosis colonies from sputum
on solid media during early TB treatment facilitates ‘persister’ phenotyping. As Time to Detection (TTD)
in liquid culture inversely correlates with total bacterial load we also evaluated the relationship between
individual colony growth parameters and TTD. Sputum from TB patients in Malawi was prepared for solid
and liquid culture after 0, 2 and 4 weeks of treatment. Serial photography of agar plates was used to
measure time to appearance (lag time) and radial growth rate for each colony. Mixed-effects modelling
was used to analyse changing growth characteristics from serial samples. 20 patients had colony mea-
surements recorded at 1 time-point. Overall lag time increased by 6.5 days between baseline and two
weeks (p ¼ 0.0001). Total colony count/ml showed typical biphasic elimination, but long lag time col-
onies (>20days) had slower, monophasic decline. TTD was associated with minimum lag time (time to
appearance of ﬁrst colony1). Slower elimination of long lag time colonies suggests that these may
represent a persister subpopulation of bacilli.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
To meet global tuberculosis (TB) control targets, shorter dura-
tion treatment regimens are needed [1]. Recent attempts to shorten
therapy for drug susceptible TB to less than 6 months in phase IIIU, colony forming units; RGR,
l Glasgow Centre for Global
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r Ltd. This is an open access articleclinical trials have resulted in high rates of treatment failure and
relapse [2e4]. Such unfavourable outcomes are often attributed to
the capacity of phenotypically drug-tolerant ‘persister’ bacilli to
survive antibiotic exposure [5,6]. Development of techniques to
monitor the speciﬁc activity of novel antimicrobial regimens
against persister cells would signiﬁcantly advance TB therapeutics
research, and help select drug combinationswith greater treatment
shortening potential [7].
Bacilli in sputum have traditionally been quantiﬁed by counting
colony forming units (CFUs) after incubation on solid media.
Mathematical modelling of serial CFU counts during TB treatment
has shown biphasic bacterial killing, supporting the hypothesis that
different sub-populations of Mycobacterium tuberculosis are elimi-
nated at different rates. However, total CFU counts do not selec-
tively identify persister organisms. In vitro experiments have usedunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ichia coli colonies, measuring their time to appearance (lag-time)
and radial growth rate (RGR) on culture plates under a range of
conditions [8]. In thesemodels, the primary adaptation to antibiotic
stress was development of drug tolerance through a population
shift in CFU lag-time distribution, without generation of resistance
mutations [9]. Incorporation of similar methodology to sputum
colony counting studies is required to test whether differential lag-
time or RGR measurements identify a persister TB phenotype from
clinical samples.
Time to detection (TTD) in liquid culture is an alternative means
of M tuberculosis quantiﬁcation [10]. There is a known negative
correlation between TTD and CFU counts, and recent studies have
modelled treatment response on the basis of changes in TTD over
time on therapy [11]. Whilst liquid culture offers several advan-
tages, including more successful revival of pesisters than solid
media, the precise relationship between TTD and CFU counts is
incompletely understood and requires further study [12,13].
For the current study we adapted the in vitro colony imaging
approach to provide lag-time and RGR measurements from indi-
vidualM tuberculosis CFUs recovered from serial sputum samples of
adult pulmonary TB patients. We assessed whether heterogeneity
in lag-time and RGR measurements revealed a sup-population of
persister organisms. We also compared these parameters to TTD
results from liquid culture of the same specimens, to provide new
information on the relationship between individual CFU growth
and TTD of the overall sample.
2. Methods
2.1. Patient selection and sample collection
The study was conducted in Blantyre, Malawi as part of a large
multicentre prospective cohort study named PanACEA Biomarkers
Expansion Project (PanBioME). Patients aged 18e65 years with
smear positive pulmonary TB (grade 2e3þ by IUATLD criteria on
Ziehl-Neelsen staining [14]) were recruited to PanBioME. Exclusion
criteria includedprevious TB treatment in the last 5 years, or inability
to complete the ﬁrst two weeks of ﬁrst-line treatment. Sputumwas
obtained by combining one overnight collection at the patient's
home with an assisted early morning collection at the Queen Eliz-
abeth Central Teaching Hospital tuberculosis service, 0, 14 and 28
days into therapy. Ethical approval was granted by the Research
Ethics Committee, College of Medicine, University of Malawi.
2.2. Sample preparation and quantitative bacteriology
Highly viscous sputum was liqueﬁed by glass-bead vortexing
with a volume of distilled water <15% of the sample volume.
Twoefour ml of un-decontaminated samples were then homoge-
nised by addition of an equal volume of working strength dithio-
threitol (Oxoid, SR0023A) and repeated light vortexing over the
next 30min. Ninety millimetre diameter plates were preparedwith
selective media (Middlebrook 7H11 oleic acid albumin agar with
MAST Selectatabs™, and carbedazim, according to a previously
published protocol from our laboratory [15]) to a depth of ~4 mm.
Six serial ten-fold dilutions (neat to 106) of the processed
sputum were prepared using the micropipetting method and
phosphate buffered saline (PBS) diluent, with vortexing and
micropipette tip change between each dilution step [15]. Each
dilution was inoculated in duplicate, using a disposable loop, onto
selective plates. Plates were then sealed using 12 mm Micropore™
tape, stored inside airtight polyethylene specimen bags and storage
boxes and incubated at 37 C in darkness, media-surface upside
with tri-weekly shufﬂing. Colony counts were performed at 4weeks, and used to calculate CFU/ml counts for original sputum by
back-calculation accounting for inoculum volume and dilution
factor. A minimum of one colony per specimen was identiﬁed as
containing acid-fast bacilli on Ziehl-Neelson microscopy, including
any colonies regarded as having ambiguous morphology.
In parallel, aliquots of each sample was processed for liquid
culture in BACTEC™ MGIT™ 960 Mycobacterial detection system
(Becton Dickinson). One millilitre homogenised sputum was
decontaminated with 1 ml N-acetyl-L-cysteine/NaOH 3% for 15 min
before inoculation into BBL-MGIT™ 7 ml tubes prepared as per
manufacturer instructions e 7 ml Middlebrook 7H9 broth base
supplemented with oleic acid, albumin, dextrose, and catalase
(BBL-MGIT™ OADC) and polymixin B, amphotericin B, nalidixic
acid, trimethoprim (BBL-MGIT™ PANTA). Isolates which signalled
positive were conﬁrmed as M. tuberculosis if they demonstrated
acid-fast bacilli with cording and MPT64Ag positivity on commer-
cial identiﬁcation kits (Becton Dickinson). TTD in hours was
retrieved from BACTEC™ MGIT™ 960 software. Only TTD results
from conﬁrmed M. tuberculosis positive cultures were used in the
analysis. Specimens which had not signalled positive by 8 weeks
were reported as negative.
2.3. Digital imaging to assess colony lag time and RGR
Media-side downplates were back-illuminated in a custom built
light box by a low-heat LED panel light for photographing three
times per week. A compact digital camera (Nikon™ Coolpix™
S6700 2.1 megapixel, settings: “MACRO”, “high quality, large im-
age”) was ﬁxed to the light box 20 cm from plate position. Plate
edges were marked to allow standardised positioning in serial
photographs and additional markings, visible in ﬁnal images,
permitted a post-hoc check for standardised positioning relative to
the camera (Figure S1, available as online supplement).
The size and position of colonies in each digital image were
measured using open source software (OpenCFU v3.9.0 beta) [16].
Combined colony observations from serial images of the same plate
were used to extract growth curves for each unique colony.
Several colony growth models (including all those previously
described in the literature [17,18]) were assessed for ﬁt against
observed growth data. A simple linear model of colony radius as a
function of time for initial colony growth (i.e. after censoring
plateau phase observations) showed better ﬁt than a mono-
exponential, biexponential, or power-law function. Therefore, an
individual linear model was ﬁtted to the initial growth of each
colony using the ordinary least squares method. Colony RGR was
deﬁned as the slope co-efﬁcient, and lag time as the x intercept, of
this model (Figure S2, available as online supplement). ‘Minimum
lag time’ was deﬁned as the shortest colony lag time observed
amongst colonies grown from a given sample.
Although every plate, at every dilution of each clinical sample
was imaged, prior work on soil microbes [19], and optimization
experiments on M tuberculosis laboratory strain H37Rv (Figure S3,
available as online supplement) have shown that the concentra-
tion of bacteria inoculated onto a culture plate (plating density)
inﬂuences the probability a CFU will form a colony, and its lag time
in doing so. Therefore, analysis of individual colony growth kinetics
from clinical samples in this study was restricted to the plate di-
lutions of each specimen which yielded a ﬁnal count of 1e50 col-
onies per plate.
2.4. H37Rv control plates
Two-hundred and sixty-nine M tuberculosis colonies grown
fromH37Rv laboratory strainwere analysed in the sameway as the
clinical isolate colony growth for comparison.
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The data structure for this study was hierarchical and nested,
with serial measures of colonies, within plates, from repeated
sampling of the same individuals at different time points. There-
fore, statistical methods that accounted for non-independence of
the observations (or their error terms) were employed, including
use of summary measures and mixed-effects modelling [20,21]. In
particular, linear mixed effects models were used to assess changes
in colony growth kinetics from patient samples collected at
different study visits. Correlations of TTD with solid media growth
characteristics were assessed with R2 from linear regression. All
data management and statistical analysis was conducted in R Stu-
dio (Version 0.98.1102) [22].
3. Results
3.1. Patients, samples and quantitative bacteriology
Twenty-one patients were recruited; 20 patients had colony
growth at one ormore treatment timepoints. Positive samples were
required for analysis of colony growth kinetics. 35 sputum speci-
mens fulﬁlled these criteria; their time-points of collection, CFU
counts and TTD data are summarised in Table 1.
3.2. Lag time and RGR of colonies recovered from clinical isolates
vary over time
Approximately 16000 digital images of inoculated plates were
captured across all specimens at all timepoints. However, based on
criteria that only colonies from plate dilutions which yielded a ﬁnal
colony count of 1e50 CFU, images of 1352 colonies were analysed,
with a median of 6 measurements of each colony.
There was no correlation between lag time and RGR for indi-
vidual colonies (Pearson's r ¼ 0.03), suggesting that these mea-
surements are independent measures of colony behaviour.
Distributions of observed colony lag times and growth rates are
shown in Figure 1. Variation in colony lag times was notably greater
for the clinical isolates compared to H37Rv control plates. For the
clinical isolates, observed colonies' mean lag time was 19.4 days in
baseline samples, 25.5 days in two-week and 23.8 days in four-
week samples. An increase in mean colony lag time between
baseline and two-weeks was seen for 8 out of 9 patients with
colony growth captured at both these time points. Linear mixed
effects modelling with a random ‘patient effect’ included suggested
a ﬁxed effect of lag time increasing by 6.5 days between baselineTable 1
Summary of samples and colony growth by time of sample collection.
Baseline (Week 0) W
Number of patients 21 1
Solid media results:
Positive (CFU counted) 19 1
Negative or contaminated 2 3
Liquid culture results:
Positive 17 7
Negative 2 3
Contaminated 2 3
Summary of colonies' growth kinetics:
Lag-time, median (IQR) 17.9 (13.6e24.1) 2
Minimum lag time 2.1 4
RGR, median (IQR) 95 (59e129) 9
Liquid culture TTD median (IQR) 117 (107e145) 2
CFU ¼ colony forming unit; IQR ¼ interquartile range; RGR ¼ radial growth rate of colony
from plate inoculation to initial colony growth, deﬁned by x intercept extrapolated from
hours.and two week colonies (95%CI 4.9e8.1 days, p ¼ 0.0001, Figure 1A).
Similarly, 5 out of 6 patients with available data showed an increase
in mean colony lag time between baseline and four week samples;
and linear mixed effects modelling estimated a ﬁxed effect of lag
time increasing by 4.7 days between baseline and four-week col-
onies (95%CI 3.6e5.7 days, p ¼ 0.0267, Figure 1A).
There was no consistent pattern for mean RGR of observed
colonies over time. Between baseline and week two samples, mean
colony growth rate increased for 5 patients and decreased for 4.
When colonies were phenotyped by both lag time and RGR
simultaneously, as in a scatter plot (Figure 1B), elimination over
time remained selective, with the marked disappearance of short
lag time colonies.3.3. Corrected colony counts show different bacterial elimination
dynamics for long versus short lag time colonies
Observed colony numbers were corrected for inoculum volume
and dilution factor to give CFU count per ml sputum. The median
total bacterial load fell by 1.5 log10 CFU/ml between baseline and
week two, and by 0.5 log10CFU/ml between week two and four,
consistent with a typical biphasic elimination. However, a different
elimination dynamic was seen for sub-populations of CFUs cat-
egorised by colony lag time as ‘short-lag’ (20 days) or ‘long-lag’
(>20 days). Median count for short-lag colonies was 1.1  105 CFU/
ml at baseline, falling by 2.5 log10 to 300 CFU/ml by week 2. Over
the same time period, median count for long-lag colonies fell by
less than 1 log10 CFU/ml, from 7.2  104 CFU/ml at baseline to
7500 CFU/ml at two weeks. Short-lag colonies therefore accounted
for the steep decline in CFU/ml in the rapid, early bactericidal phase
of treatment, while long-lag colonies showed a constant rate of
elimination over the ﬁrst 4 weeks of therapy (Figure 2).3.4. TTD in MIGIT correlates with minimum colony lag time and
CFU count
TTD in MGIT of each sputum sample with conﬁrmed
M. tuberculosis growth (n ¼ 29) was compared to summary mea-
sures of solid media colony growth. As expected, samples with
short TTD in MGIT had higher CFU count, with strong negative
linear correlation between TTD and log10 CFU/ml (R2 0.41,
p¼ 0.0002). Minimum lag time for a discrete colony also correlated
with TTD in liquid culture (R2 0.18, p ¼ 0.02). By contrast, mean lag
time, minimum RGR, maximum RGR, and mean RGR all showed no
correlation with TTD.eek 2 Week 4 H37Rv colonies
3 12 e
0 6 e
6 e
5 e
1 e
6 e
5.9 (21.5e29.6) 22.7 (19.4e26.5) 20.0 (17.0e22.2)
.3 11.6 5.7
2 (65e130) 122 (93e157) 182 (134e226)
10 (147e308) 270 (267e304) e
during initial linear growth phase, in micrometres per day; lag time ¼ time in days
initial observed colony growth; TTD ¼ time to detection by MGIT broth culture, in
Figure 1. Observed distributions of colonies' lag times and growth rates change over time on treatment. A. Box plots showing lag times (top) and radial growth rates (bottom)
of observed H37Rv plate colonies (n ¼ 269), and observed colonies recovered from clinical isolates (n ¼ 1352) at three time points into treatment (0, 2, and 4 weeks). Box shows
median and interquartile range. B. Scatterplots of lag time and growth rate for colonies recovered from clinical isolates at the 3 treatment time points. Partitioning the colonies
above and below the overall median lag time of 20 days, indicated by red circle and green triangle markers, shows that bacilli forming colonies with shorter lag time are the
dominant sub-population at baseline, but are a minority after 2 or 4 weeks of treatment.
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strongly collinear, so their independent effects on TTD could not be
reliably assessed in a multivariate analysis.
4. Discussion
This study is the ﬁrst to quantitatively describe individual
M. tuberculosis colony growth from clinical samples, and reports
novel ﬁndings which suggest persister cells form colonies with
longer lag times compared to bacilli which are rapidly eliminated
by anti-tuberculosis treatment.
Pharmacodynamic modelling studies have previously reported
biphasic elimination of sputum CFU counts over time on ﬁrst-line
TB treatment [23]. This may represent differential killing of bacil-
lary sub-populations with metabolically quiescent organisms
exhibiting antibiotic tolerance and surviving longer, and it has been
proposed that modelling the slower second phase of elimination is
a potential surrogate for long-term clinical outcome [11,24]. The
current study is the ﬁrst to measure phenotypic heterogeneity of
M. tuberculosis colonies obtained from sputum samples, and ad-
vances the sub-populations hypothesis by showing that distribu-
tions of colony growth kinetics vary non-randomly over the three
time points assessed (baseline, week 2, week 4). In particular,
counts of longer lag-time colonies (>20 days) decline more slowly
than shorter lag-time colonies, and show linear decline when
counts are aggregated across samples from different individuals.One interpretation of these data is that a sub-population of
M. tuberculosis cells infecting the human host are stochastically
generated with long lag-time and relative drug tolerance before
antibiotic insult, and become the dominant phenotype through
population restructuring after antibiotic exposure. Such a bet-
hedging strategy is described for other bacteria, and has been
designated type II persister formation [25,26]. For example, when
bacteria are grown in vitro before inoculation onto solid media the
distribution of resulting colony lag-times reﬂects the conditions of
the original culture (e.g. nutrient restriction), and longer average
lag times are associated with drug tolerance. By measuring indi-
vidual colony growth for E. coli strains, Levin-Reisman et al.
correlated the magnitude of the resulting long lag-time ‘tail’ with
the proportion of bacteria able to survive antibiotic exposure [8].
Should the long lag-time colonies described in our analyses truly
represent a metabolically quiescent sub-population of drug
tolerant M. tuberculosis cells, their existence might directly reveal
the mechanism of biphasic bacillary clearance, and measuring their
elimination rate may help predict the risk of eventual TB treatment
failure or post-treatment relapse.
Alternative explanations of our ﬁndings are possible. Long lag-
time colony count dynamics may not reﬂect population restruc-
turing, but simply that bacilli damaged by antibiotics have longer
lag times, or a post-antibiotic effect is being observed. However,
prior reports that treatment outcomes can be predicted from 2
month sputum culture conversion rate [27], or the rate of bacillary
Figure 2. CFU elimination from sputum over ﬁrst 4 weeks treatment shows different dynamics for short and long lag time colonies. Each data point represents a colony count
for an individual patient sputum sample, averaged across usable plate replicates; each patient therefore contributes one colony count at each timepoint, less data points at later
timepoints results from higher rates of culture negativity, contamination, and loss to follow up (n ¼ 19 at 0 weeks, n ¼ 10 at 2 weeks, n ¼ 6 at 4 weeks). A. CFU count per ml sputum
for patients at baseline, 2 weeks, and 4 weeks into treatment were multiplied by the proportion of observed colonies which had lag time 20 days in the sample, giving a ‘short lag
CFU’ count per ml. A segmented line of best ﬁt e allowed to bend at one point as shown e reduces residual sum of squares (RSS) compared to a single gradient line of best ﬁt with a
trend towards statistical signiﬁcance for the improved ﬁt (segmented linear regression RSS ¼ 18.1, unsegmented linear regression RSS ¼ 20.2; comparison by ANOVA, p ¼ 0.09). B.
CFU count per ml sputum multiplied by proportion of observed colonies with lag time >20 days in sample, giving elimination kinetics of ‘prolonged lag CFU’. Fitting a segmented
line of best ﬁt does not improve residual sum of squares compared with single gradient line of best ﬁt (segmented linear regression RSS ¼ 21.5, unsegmented linear regression
RSS ¼ 21.5; comparison by ANOVA, p ¼ 0.93). Samples with zero short lag CFU (below limit of detection) were excluded to allow plotting on the log scale (n ¼ 4 samples). Shaded
areas show 95% conﬁdence intervals around line of best ﬁt.
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persisters exist in sputum and that their phenotypic characteristics
are likely to be relevant to clinical endpoints.
Serial sputum CFU counting is labour intensive, prone to experi-
mental error, and shows systematic variation between laboratories.
TTD in commercially available liquid culture systems is a convenient,
readily standardised technique displaying moderate-strong corre-
lation with colony counts, and is increasingly used as an alternative
measurement. In addition, liquid culture has better sensitivity for
reviving M tuberculosis at later timepoints in TB treatment, sug-
gesting that it may be preferential for studying bacterial persistence
[12,28,29]. However, TTD is a summarymeasuremente inwhich the
ﬂuorescent signal conferring a positive result is driven by oxygen
consumption by the entire batch culturee and no prior studies have
assessed its relationship with the growth kinetics of individual col-
onies. Our description of a correlation between TTD and minimum
colony lag time on solid media raises the possibility that TTD is
disproportionately inﬂuenced by the shortest-lag-time CFUs in
clinical samples. Insofar as long lag-time colonies are an important
contributor to bacterial persistence, overreliance on TTD may be
unsatisfactoryand it is important that serial CFU counting techniques
are retained. Furthermore, the known non-linearity between
log10 CFU count and TTD outside of the midrange [12,13] could be
partly explained by the confounding effect of CFU lag time distri-
bution on the relationship between CFU count and TTD.
Despite the novel insights from our work, several limitations
should be highlighted. Whilst our assessment of individual colonies
generated a uniquely detailed dataset, the methods involved were
labour-intensive and the number of patients included in the project
was small. For the measure ‘proportion of colonies with lag time
>20 days’, the unit of analysis is an individual sputum sample and
only six patients had colony growth recorded from all three time
points. In addition, the data is imbalanced, with some sputum
samples' generating >10 fold more observed colonies than others.
Larger studies, with longer follow-up will be required to conﬁrmour exploratory ﬁndings and directly relate individual colony
growth characteristics to clinical treatment response.
Overall, we have shown that phenotypic heterogeneity in
M. tuberculosis colonies recovered from clinical specimens can be
quantiﬁed using image analysis, providing novel pharmacody-
namic insights. Slower elimination of CFU forming long lag time
colonies suggests that these may represent type II persister bacilli.
Further development of colony image analysis could prove useful in
addressing fundamental research questions in tuberculosis drug
therapy.
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